HIGHLIGHTS
- who: Report and colleagues from the College, Vellore, IND Critical Care Medicine, Mayo Clinic, Rochester, USA have published the paper: Review began 02/10/2023 Review ended 02/27/2023 Published 03/01/2023 u00a9 Copyright, in the Journal: (JOURNAL) of March/01,/2023
- what: Our patient developed pulmonary cryptococcosis that was managed with fluconazole, which is the first-line treatment, with significant clinical improvement.
SUMMARY
More than two years into the pandemic, clinicians have begun encountering post-coronavirus disease 2019 (COVID-19) sequelae and long-term complications. Acute respiratory distress . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.